Avista Therapeutics Expands Its AI Gene Therapy Platform

Avista Therapeutics has expanded its gene therapy platform to take on some of the field's hardest delivery problems. The company recently announced that it is scaling up its capsid design program with artificial intelligence and adding a new Innovation Platform, work it says targets long-standing barriers in AAV capsid engineering, large gene delivery and manufacturing.